Patents by Inventor Peter C. R. Emtage

Peter C. R. Emtage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stem cell factor-like proteins and uses thereof
    Patent number: 7674890
    Abstract: The invention relates to pharmaceutical compositions comprising gastrointestinal proliferative factor SCFA2, SCFA4 or SCFA4v polynucleotides and polypeptides. The invention further relates to the therapeutic use of SCFA2, SCFA4 or SCFA4v to prevent or treat conditions or disorders associated with the degeneration of the epithelial mucosa.
    Type: Grant
    Filed: April 1, 2008
    Date of Patent: March 9, 2010
    Assignee: Arca Biopharma, Inc.
    Inventors: Bryan J. Boyle, Peter C. R. Emtage, Walter Funk, Y. Tom Tang, Jingsong Zhao
  • Stem cell factor-like proteins and uses thereof
    Patent number: 7439327
    Abstract: The invention relates to pharmaceutical compositions comprising gastrointestinal proliferative factor SCFA2, SCFA4 or SCFA4v polynucleotides and polypeptides. The invention further relates to the therapeutic use of SCFA2, SCFA4 or SCFA4v to prevent or treat conditions or disorders associated with the degeneration of the epithelial mucosa.
    Type: Grant
    Filed: January 17, 2006
    Date of Patent: October 21, 2008
    Assignee: Nuvelo, Inc.
    Inventors: Bryan J. Boyle, Peter C. R. Emtage, Walter Funk, Y. Tom Tang, Jingsong Zhao
  • Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells
    Patent number: 7029677
    Abstract: Certain cells, including types of cancer cells such as lymphomas, are capable of expressing high levels of CD84Hy1. Immunotargeting using CD84Hy1 polypeptides, nucleic acids encoding for CD84Hy1 polypeptides and anti-CD84Hy1 antibodies provides a method of killing or inhibiting that growth of CD84HY1Protein-expressing cancer cells. Methods of immunotherapy and diagnosis of disorders associated with CD84Hy1protein-expressing cells are described.
    Type: Grant
    Filed: December 19, 2002
    Date of Patent: April 18, 2006
    Assignee: Nuvelo, Inc.
    Inventors: Douglas Dedera, Jian-Rui Wang, Peter C. R. Emtage